Kiadis Pharma Granted U.S. Patent for its Blood Cancer Treatment ATIR

Kiadis Pharma B.V. , a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that it has received a Notice of Allowance for its U.S. Patent Application No.

http://www.b3cnewswire.com/20130121825/kiadis-pharma-granted-us-patent-for-its-blood-cancer-treatment-atir-tm.html